EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Multizentrische StudieOpen Access · CC BY-NC 4.0

Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods

Félicien Le Louedec, Laura Morvan, Loïc Mourey, Maud Maillard, Christelle Vachoux, Malika Yakoubi, Diego Tosi, Gwenaelle Gravis, Guilhem Roubaud, Frédéric Thuillier, Helen Boyle, Fabienne Thomas und 3 weitere

Clinical Pharmacokinetics · 2026-05 · 65 (5) · 681-692

DOI: 10.1007/s40262-026-01628-2 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift Clinical Pharmacokinetics, 2026-05. Verfasst von Félicien Le Louedec und 14 weiteren Autor:innen. Beteiligte Einrichtung: Univ Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Inserm, CRCT, Toulouse, France. Hauptthemen laut MEDLINE: Kidney Neoplasms, Models, Biological, Protein Kinase Inhibitors, Pyrimidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsModels, BiologicalProtein Kinase InhibitorsPyrimidinesSulfonamidesFemaleHumansMaleAntineoplastic AgentsBayes TheoremDrug MonitoringIndazolesPrecision MedicineSunitinib

Substanzen

Antineoplastic AgentsIndazolespazopanibProtein Kinase InhibitorsPyrimidinesSulfonamidesSunitinib

Autor:innen und Institutionen

  • Univ Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Inserm, CRCT, Toulouse, France.
  • Department of Medical Oncology, Univ Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • Univ Toulouse, Inserm, CRCT, Toulouse, France.
  • IRCM, Montpellier, France.
  • Department of Medical Oncology, Institut Paoli Calmettes, Aix Marseille Univ, INSERM, CNRS, CRCM, Marseille, France.
  • Department of Medical Oncology, Institut Bergonié, Bordeaux, France.

ORCID-Profile: Étienne Chatelut

Zitieren

APA

Le Louedec, F., Morvan, L., Mourey, L., Maillard, M., Vachoux, C., Yakoubi, M., Tosi, D., Gravis, G., Roubaud, G., Thuillier, F., Boyle, H., Thomas, F., White-Koning, M., Puisset, F., & Chatelut, É. (2026). Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-026-01628-2

Vancouver

Le Louedec F, Morvan L, Mourey L, Maillard M, Vachoux C, Yakoubi M, et al. Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods. Clinical Pharmacokinetics. 2026. doi:10.1007/s40262-026-01628-2

BibTeX
@article{LeLouedec2026,
  author = {Le Louedec, Félicien and Morvan, Laura and Mourey, Loïc and Maillard, Maud and Vachoux, Christelle and Yakoubi, Malika and Tosi, Diego and Gravis, Gwenaelle and Roubaud, Guilhem and Thuillier, Frédéric and Boyle, Helen and Thomas, Fabienne and White-Koning, Mélanie and Puisset, Florent and Chatelut, Étienne},
  title = {Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors Methods},
  journal = {Clinical Pharmacokinetics},
  year = {2026},
  doi = {10.1007/s40262-026-01628-2}
}
Kostenlos starten →